Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice

Abstract Schizophrenia is a psychiatric disorder that affects around 1% of the population in widespread populations, with severe cases leading to long-term hospitalization and necessitation of lifelong treatment. Recent studies on schizophrenia have highlighted the involvement of inflammatory and im...

Full description

Bibliographic Details
Published in:	Molecular Brain
Main Authors:	Siyao Li, Koki Sakurai, Masahiro Ohgidani, Takahiro A. Kato, Takatoshi Hikida
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Subjects:	Short-term cuprizone exposure Psychosis Fingolimod Microglial activation Neuroinflammation
Online Access:	https://doi.org/10.1186/s13041-023-01047-5

Similar Items

FTY720-derivatives do not induce FTY720-like lymphopenia
by: Ismael Segura-Ulate, et al.
Published: (2017-03-01)

Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
by: H.C. Hoyos, et al.
Published: (2014-02-01)

Fingolimod (FTY720) Tedavisinin Relapsing-Remitting Multipl Skleroz Hastalarında Karaciğer Enzim Düzeylerine Etkisi
by: Duygu Tap, et al.
Published: (2020-12-01)

The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
by: Stradner Martin H, et al.
Published: (2011-12-01)

Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice
by: Josh M. Krivinko, et al.
Published: (2022-01-01)

Behavioral Analyses in Dark Agouti Rats Following Repeated Systemic Treatment With Fingolimod (FTY720)
by: Marie Jakobs, et al.
Published: (2024-11-01)

Effect of FTY720 on Angiotensin Ⅱ-mediated chronic kidney diseases
by: HAN Qi, et al.
Published: (2019-01-01)

Age Influences Microglial Activation After Cuprizone-Induced Demyelination
by: Barbara Klein, et al.
Published: (2018-09-01)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
by: Kathrin Bail, et al.
Published: (2017-07-01)

FTY720 Reduces the Biomass of Biofilms in <i>Pseudomonas aeruginosa</i> in a Dose-Dependent Manner
by: Abdurahman A. Niazy, et al.
Published: (2024-07-01)

Microglial depletion exacerbates axonal damage and motor dysfunction in mice with cuprizone-induced demyelination
by: Shinji Yamamoto, et al.
Published: (2023-11-01)

Investigation of the Effects of Fingolimod on the LPS-Induced Inflammatory Response in the HUVEC Cell Line
by: Hamza Halıcı, et al.
Published: (2025-07-01)

Deep rTMS Mitigates Behavioral and Neuropathologic Anomalies in Cuprizone-Exposed Mice Through Reducing Microglial Proinflammatory Cytokines
by: Liu Yang, et al.
Published: (2020-11-01)

Toxicidad hepática por fingolimod
by: juan sebastian theran leon, et al.
Published: (2024-02-01)

The Cuprizone Model: Dos and Do Nots
by: Jiangshan Zhan, et al.
Published: (2020-03-01)

Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model
by: Mariela Wittekindt, et al.
Published: (2022-05-01)

Sex-dependent efficacy of sphingosine-1-phosphate receptor agonist FTY720 in mitigating Huntington’s disease
by: Jingyun Wu, et al.
Published: (2025-01-01)

Molecular and Cellular Mechanisms of Fingolimod Action
by: A. V. Nikitin
Published: (2020-05-01)

Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018-03-01)

Fingolimod-associated severe bilateral cystoid macular edema
by: Hideki Fukuoka, et al.
Published: (2022-06-01)

The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
by: Masayo Aoki, et al.
Published: (2020-01-01)

Fingolimod (FTY720) stimulates Ca(2+)/calcineurin signaling in fission yeast.
by: Kanako Hagihara, et al.
Published: (2013-01-01)

A Validated HPLC-MS/MS Method for Quantification of Fingolimod and Fingolimod-Phosphate in Human Plasma: Application to Patients with Relapsing–Remitting Multiple Sclerosis
by: Claudia Fracasso, et al.
Published: (2022-06-01)

Protective Role of α-Pinene in Cuprizone-Induced Multiple Sclerosis in Mice
by: Shahin Hassanpour, et al.
Published: (2023-02-01)

Melatonin ameliorates astrogliosis and microgliosis in a cuprizone demyelinating mouse model
by: Mehdi Alidadi, et al.
Published: (2025-03-01)

Weight Loss and Fingolimod
by: Nefati Kıylıoğlu
Published: (2017-12-01)

Cuprizone Affects Hypothermia-Induced Neuroprotection and Enhanced Neuroblast Differentiation in the Gerbil Hippocampus after Ischemia
by: Woosuk Kim, et al.
Published: (2020-06-01)

Molluscum contagiosum eruption in an adult patient using fingolimod and review of the literature
by: Sibel Yavuz, et al.
Published: (2023-12-01)

Could Fingolimod Combined with Bevacizumab Be a New Hope in Glioblastoma Treatment?
by: Murat Baloglu, et al.
Published: (2025-05-01)

Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model
by: Stefan Gingele, et al.
Published: (2020-04-01)

Curcumin-piperine nanoparticles mitigate cuprizone-induced cognitive impairment via antioxidant and anti-inflammatory mechanisms
by: Mohammad Zubair Alam, et al.
Published: (2025-10-01)

FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.
by: Nobumasa Takasugi, et al.
Published: (2013-01-01)

Protective effect of the Quercetin on experimental cuprizone-induced multiple sclerosis in male C57BL/6 mice
by: Samin Ghasemi, et al.
Published: (2025-01-01)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
by: Saeed Vaheb, et al.
Published: (2023-04-01)

Whole-brain ex-vivo quantitative MRI of the cuprizone mouse model
by: Tobias C. Wood, et al.
Published: (2016-11-01)

Fingolimod-associated cryptococcal meningitis in a patient with Multiple Sclerosis: A case report and literature review
by: Hidenori Nakagawa, et al.
Published: (2025-01-01)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by: Paul Dent, et al.
Published: (2020-01-01)

Inhibiting microglia exacerbates the early effects of cuprizone in males in a rat model of multiple sclerosis, with no effect in females
by: Soniya Xavier, et al.
Published: (2023-09-01)

Ferulic Acid Ameliorates Cell Injuries, Cognitive and Motor Impairments in Cuprizone-Induced Demyelination Model of Multiple Sclerosis
by: Mojtaba Ghobadi, et al.
Published: (2022-11-01)

Effects of FTY720 (Fingolimod) on Proliferation, Differentiation, and Migration of Brain-Derived Neural Stem Cells
by: Botao Tan, et al.
Published: (2016-01-01)